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Microbial resistanceAbstract The compound 4-(Phenylsulfonyl) morpholine belongs to the class of sulfonamides,
which are widely used in the treatment of a large number of diseases caused by microorganisms.
This compound has a morpholine group, which is also known for its antimicrobial properties.
The aim of the present study was to investigate the antimicrobial and modulating activity of
4-(Phenylsulfonyl) morpholine against standard and multi-resistant strains of Staphylococcus
aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and strains of the fungi
Candida albicans, C. tropicalis and C. krusei. Antimicrobial activity was assessed based on the mini-
mum inhibitory concentration (MIC) using the microdilution method. MIC wasP1024 lg/mL for
all microorganisms. Regarding modulating activity, the most representative effect occurred with the
combination of 4-(Phenylsulfonyl) morpholine at a concentration of 128 lg/mL (MIC 1/8) and
amikacin against P. aeruginosa 03, with a reduction in MIC from 312.5 to 39.06 lg/mL.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sulfonamides are substances with structures correlative to that
of p-aminobenzoic acid. As competitive antagonists, sulfon-
amides impede their use by bacteria in the synthesis of folic
acid, thereby affecting microorganisms that need to synthesize
their own folic acid. As mammals do not synthesize folic acid,
sulfonamides do not affect their metabolism (Alaburda et al.,
2007). The importance of the sulfonamide nucleus is well
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5-substituted amino pyrazole sulfates in an attempt to ﬁnd a
therapeutic alternative for combating infection (Borges et al.,
2004). A number of sulfonamides, especially those derived
from p-aminobenzenesulfonamide, have structural variations
that enhance their efﬁcacy to obtain a greater action spectrum
and increase their solubility in biologic systems (Coutinho
et al., 2008a).
Morpholine derivatives constitute a new antifungal chemi-
cal group not correlated with other currently available medica-
tions with antifungal activity. These derivatives inhibit the
biosynthesis of sterol by blocking two successive enzymatic
processes: (1) inhibiting the biotransformation of lanosterol
into zymosterol by blocking the enzyme C-14 sterol reductase
and; (2) inhibiting the synthesis of ergosterol from the bio-
transformation of fecosterol into episterol by blocking the
enzyme C-8 sterol isomerase; these enzymes are different from
those inhibited by allylamines or azoles (Kerkenaar, 1987;
Polak, 1988). The advantage in preparing morpholine deriva-
tives resides in the fact that these compounds provide chlorhy-
drates that are soluble in water for pharmacological assays
(Pinto et al., 2013). Different sulfonyl-hydrazones obtained
from sulfonyl chloride exhibit anti-neoplasm, antibacterial,
antinociceptive and other pharmacological activities against
several and different targets (Oliveira, 2012). Synthetic sub-
stances have demonstrated efﬁcacious antimicrobial action
against resistant microorganisms. The determination of syner-
gism or antagonism between antimicrobial agents is important
to understanding the action mechanisms of these substances as
well as resistance mechanisms. Moreover, in vivo and in vitro
analyses are performed for the detection of therapeutic
potential with the aim of ﬁnding alternative pathogen control
methods (Cata˜o et al., 2010).
The aim of the present study was to investigate the
antimicrobial and modulating activity of 4-(Phenylsulfonyl)
morpholine against standard and multi-resistant strains of
Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae,
Pseudomonas aeruginosa and strains of the fungi Candida
albicans, Candida. tropicalis and Candida. krusei.
2. Materials and methods
2.1. Synthesis
The precursor’s benzenesulfonyl chloride and morpholine
were purchased commercially from Sigma–Aldrich (St. Louis,
USA). The precursors were used without further puriﬁcation.
The title compound 4-(Phenylsulfonyl) morpholine was
prepared by reaction of 1 equivalent of benzenesulfonyl chlo-
ride (1 mmol) and morpholine (2 mmol) in methanolic mixture
of pyridine (5 mL) at low temperature (0 C) under stirring
by 2 h as a previously described procedure (Buchmann andS
O
O
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HN
O
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Figure 1 Synthesis of the compound 4-(PhSchalinatus, 1962). The material thus formed was ﬁltered
and washed with methanol solution then dried. The resulting
material was recrystallized by using heating methanol solution.
The crystals were formed by slow solvent evaporation at room
temperature. The complete structure elucidation was con-
ﬁrmed by NMR 1H and 13C spectroscopy analysis by compar-
ison with literature data (Modarresi-Alam et al., 2009). The
NMR spectra in CDCl3, were recorded in Varian-Mercury
300 (300 MHz for 1H and 75 MHz for 13C) spectrometer, using
tetramethylsilane (TMS) as internal standard. Analytical
Data: 1H RMN (CDCl3, 300 MHz): t (4H; 3.01 ppm); t (4H;
3.74 ppm); t (2H, J= 7.56 Hz); t (1H; 7.64 ppm); d (2H;
7.77 ppm) 13C RMN (CDCl3, 75 MHz): d= 46; 66.10;
127.85; 129.15; 133.09; 135.13. The synthesis is described by
the scheme present in Fig. 1.
2.2. Microorganisms
The following strains were used: E. coli ATCC10536 and
E. coli EC 27; S. aureus ATCC25923 and S. aureus SA358;
P. aeruginosa ATCC15442 and P. aeruginosa PA; C. albicans
ATCC40006; C. krusei ATCC6258 and C. tropicalis
ATCC13803. Table 1 displays the resistance proﬁle of the
microorganisms. All strains were maintained on heart infusion
agar (HIA, Difco Laboratories Ltd., San Diego, USA). Prior
to the assays, the strains were cultivated in Brain-Heart Infu-
sion broth (BHI, Difco Laboratories Ltd., San Diego, USA)
for 18 h at 37 C.
2.3. Antimicrobial activity and antibiotic modulating activity
The minimum inhibitory concentration (MIC) of all microor-
ganisms was determined in broth microdilution assays (CLSI,
2005) using an inoculum of 100 lL of each strain suspended in
BHI broth at a concentration of 105 colony forming units/mL
in 96-well microtitration plates, with dilutions in ½ series. An
aliquot of 100 lL of 4-(Phenylsulfonyl) morpholine was added
to each well. The ﬁnal concentrations of the substance ranged
from 512 to 8 lg/mL. The standard antibiotics (amikacin,
gentamicin and neomycin) and antifungals (amphotericin B,
benzoilmetronidazol, mebendazole and nystatin) were assayed
at concentrations ranging from 512 to 8 lg/mL and were used
as controls. The plates were incubated at 35 C for 24 h, after
which the readings were performed with the aid of resazurin.
The MICs were recorded as the least concentration necessary
to the growth inhibition. For the assessment of the substance
as a modulator of antibiotic and antifungal action, the MIC
of antibiotics and antifungals was evaluated in the presence
and absence of the substance in sterile microplates. The antibi-
otics and antifungals were analyzed at concentrations ranging
from 512 to 0.5 lg/mL. All antibiotics tested were obtained
from Sigma–Aldrich (St. Louis, USA).NO S
O
O
enylsulfonyl) morpholine (C10H13NO3S).
Table 1 Bacterial strains origin and resistance proﬁle.
Bacteria Origin Resistance proﬁle
Escherichia coli 27 Surgical wound AZT, AMI, AMP, CFR, KAN, CAZ, CCL, CF, CIP, CHL, IMI, SXT, TET, TOB
Escherichia coli ATCC10536 – –
Staphylococcus aureus 358 Surgical wound AMI, BUT, KAN, GEN, NEO, NET, OXA, PARA, SIS, TOB
Staphylococcus aureus ATCC25923 – –
Pseudomonas aeruginosa 03 Uroculture AMI, CIP, CPM, CAZ, IMI, LEV, MEM, PTZ
P. aeruginosa ATCC 15442 – –
Candida albicans ATCC 40006 – –
Candida krusei ATCC 6258 – –
Candida tropicalis ATCC 13803 – –
AZT – Aztreonam; Amp – Ampicillin; AMI – Amikacin; CFR – Cefadroxil; KAN – Kanamycin; CAZ – Ceftazidime; CIP – Ciproﬂoxacin;
CCL – Cefaclor; CF – Cephalothin; CHL – Chloramphenicol; IMI – Imipenem; SXT – Sulfamethoxazole and Trimethoprim;
TET – Tetracycline; TOB – Tobramycin; BUT – Butirosin; GEN – Gentamicin; NEO-Neomycin; NET – Netilmicin; OXA – Oxacillin;
PARA – Paromomycin; SIS – Sisomicin; CPM – Cefepime; CAZ – Ceftazidime; PTZ – Piperacillin-tazobactam; LEV – Levoﬂoxacin;
MEM – Meropenem.
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broth at sub-inhibitory concentrations, which were determined
during the MIC evaluation tests. For the modulation test, the
concentration of the extract solution was reduced eight fold
(MIC/8). The preparation of the antibiotic solutions was per-
formed with the addition of sterile distilled water at double
concentration (1024 lg/mL) in relation to the initially deﬁned
concentration and volumes of 100 lL serially diluted (propor-
tion: 1:1) in 10% BHI broth. Each well with 100 lL of the
culture medium contained the diluted bacterial suspension
(proportion: 1:10). The controls for the modulation assays
were the same as those used in the MIC assays (Coutinho
et al., 2008b). The plates were incubated at 35 C for 24 h, after
which the reading was performed with the aid of resazurin.
The antimicrobial assays were carried out in triplicate, with
mean values used for the analysis.
3. Results and discussion
The MIC of the compound was >512 lg/mL for all bacterial
(E. coli, S. aureus and P. aeruginosa) and fungal (C. albicans,
C. krusei and C. tropicalis) strains, demonstrating a lack of
clinical signiﬁcance within the limits established by the proto-
col (Sriram et al., 2010). Moreover, a pilot test was performed
using DMSO alone and no antimicrobial or modulating activ-
ity was found, indicating a lack of toxicity.
Table 2 displays the effect of 4-(Phenylsulfonyl) morpholine
on aminoglycoside activity, demonstrating modulation of the
activity of amikacin and gentamicin, with a reduction in
MIC against the Gram-negative strains. The most representa-
tive effect was obtained with the combination of 4-(Phenylsul-
fonyl) morpholine at a concentration of 128 lg/mL (MIC 1/8)Table 2 MIC values (128 lg/mL) of aminoglycosides in the absence
multiresistant strains.
Antibiotic EC27 SA358
MIC MIC combined MIC
Amikacin 78.125 19.53 39.06
Gentamicin 39.06 9.76 4.88
Neomycin 156.25 156.25 156.25
EC27 – Escherichia coli; SA358 – Staphylococcus aureus; PA03 – Pseudoand amikacin against PA 03, with a reduction in the MIC from
312.5 to 39.06 lg/mL. In contrast, the substance demonstrated
no capacity to modulate the action of aminoglycosides against
strains of S. aureus. These ﬁndings are in agreement with data
reported in the literature testing synthetic products against
bacteria for the reduction of microbial resistance (Sriram
et al., 2010; Ravat et al., 2009; Zhanel et al., 2009).
The synergism found in the modulation of antibiotic activ-
ity against E. coli and P. aeruginosa may be explained by the
fact that 4-(Phenylsulfonyl) morpholine is derived from sulfon-
amides. This class of antibiotics is represented in therapy by
sulfamethoxazole, the action mechanism of which consists of
the blocking of the enzyme dihydropteroate synthase in bacte-
ria. Sulfonamides are bacteriostatic agents that act as anti-
metabolites of p-aminobenzoic acid, which is the substrate
for bacterial dihydropteroate synthase, impeding the forma-
tion of the dihydropteroate and, consequently, the formation
of N5,N10-methylenetetrahydrofolate (Halland et al., 2014).
The morpholine group may also have affected the antimi-
crobial activity against E. coli and P. aeruginosa, as a study
involving the combination of morpholine and dimorpholine
demonstrated efﬁcacy against bacteria and yeasts. The same
study reports a signiﬁcant decrease in fungal contamination
(99.9%) and the degree of efﬁcacy against this microorganism
was maintained for a period of 28 days (Takahashi, 2012). In
contrast, no signiﬁcant results were achieved with regard to
the strains of Candida tested.
The lack of modulating activity in neomycin against all
strains may be explained by the difference in the structure of
this aminoglycoside, which is a hydrophilic molecule com-
posed of an aminocyclitol ring linked to one or more amino
sugar through a glycosidic bond. In most of these compoundsand presence of the compound 4-(Phenylsulfonyl) morpholine in
PA03
MIC combined MIC MIC combined
39.06 312.5 39.06
4.88 39.06 9.76
156.25 312.5 312.5
monas aeruginosa; MIC – Minimum inhibitory concentration.
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treptamine, which can be substituted in the 4 and 5 or 4 and
6 position (Magnet and Blanchad, 2005), thereby inﬂuencing
the solubility, polarity and absorption of the drug.
Due to absorption to the intercellular space, a toxic effect is
common to all aminoglycosides, except spectinomycin. Renal
toxicity causes nerve damage, being the oto/neurotoxicity the
main toxic effect of aminoglycosides (Vallejo et al., 2001;
Oliveira et al., 2006).
Thus, the combination of compounds with aminoglycosides
may be an option to minimize undesirable effects when used
for the treatment of infection by E. coli and P. auruginosa,
since such combinations have a synergic effect, with a consid-
erable reduction in the MIC of these drugs, allowing the reduc-
tion of the essential dose necessary for treatment success
(Figueredo et al., 2013).
The lack of a signiﬁcant effect against S. aureus may be
explained by the fact that this microorganism has a number
of virulence mechanisms and a high degree of versatility
regarding pathogenic strategies, which enhances its resistance
to antibiotics (Coutinho et al., 2008a; Tavares, 2000). Epi-
demiological studies evaluating the resistance of S. aureus
report mean resistance rates of 63.25%, 76.5%, 56% and
71.25% to ciproﬂoxacin, clindamycin, tetracycline and
trimethoprim–sulfamethoxazole, respectively (Almeida et al.,
2007).
4-(Phenylsulfonyl) morpholine exhibited no signiﬁcant
modulating effect on the antifungal agents amphotericin B,
benzoilmetronidazol, mebendazole and nystatin against
C. albicans, C. tropicalis or C. krusei. The ﬁndings are in agree-
ment with previous study demonstrating fungal resistance
(Silva, 2009). This resistance may occur due to the presence
of chitin in the cell wall of these microorganisms, which serves
as structural support (Merzendorfer and Zimoch, 2003). As
chitin is insoluble in most solvents, it hinders the entrance of
the antifungal agent (Mathur and Narang, 1990).
4. Conclusion
The MIC of 4-(Phenylsulfonyl) morpholine was >512 lg/mL
for all bacterial and fungal strains tested, demonstrating a lack
of antimicrobial activity. However, when used as a modulating
agent of amikacin and gentamicin, the synthetic substance
tested lowered the MICs of these aminoglycosides against
Gram-negative strains. This ﬁnding demonstrates that
4-(Phenylsulfonyl) morpholine has antibacterial and antibiotic
modulatory activities, being this synthetic compound an
interesting weapon against drug resistant bacteria. However,
more data, mainly toxicological assays must be performed
before this use.
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